BioCentury
ARTICLE | Company News

Anaptys, U.S. Department of Defense other, antibodies news

May 20, 2013 7:00 AM UTC

AnaptysBio received a contract from the DoD's Defense Threat Reduction Agency (DTRA) to develop highly thermostable anti-ricin antibodies using its SHM-XEL technology for biodefense applications. The ...